AVIXAA Medical Nutraceuticals are developed at the intersection of molecular dermatology and nutritional biochemistry. Recognizing that dermal integrity, collagen bundle cross-linking, and cellular resilience originate from internal physiology, our nutraceutical matrix delivers targeted bioactive molecules at therapeutic clinical dosages.
Unlike commercial over-the-counter collagen drinks, AVIXAA formulas use low-molecular-weight (<2.0 kDa) bioactive collagen hydrolysates with clinically substantiated GI tract absorption and documented fibroblast signaling stimulation.
Clinical Formulations in This Portfolio
- BioCellular Collagen Peptide Matrix: Ultra-purified marine oligopeptides optimized for rapid enterocyte uptake, increasing dermal pro-collagen type I mRNA expression by up to 65% in clinical cohorts.
- Cellular Photo-Defense Capsules: High-potency systemic antioxidant complex containing polypodium leucotomos extract, astaxanthin, and liposomal glutathione to reduce UV-induced matrix metalloproteinase (MMP-1) activation.
- Dermal Micronutrient & Trace Mineral Complex: Precision co-factors including bioavailable zinc bisglycinate, copper tripeptide precursors, and methylsulfonylmethane (MSM) supporting keratin and elastin synthesis.
- Post-Procedure Vascular & Anti-Edema Formula: Standardized bromelain, rutin, and arnica bioflavonoids accelerating ecchymosis resolution after injectables and surgical interventions.
Our clinical nutraceuticals are strictly physician-prescribed to ensure comprehensive patient monitoring and alignment with in-clinic aesthetic procedures.
BioCellular Collagen Matrix
Ultra-purified marine oligopeptides (<2.0 kDa) with CoQ10 stimulating endogenous pro-collagen type I mRNA synthesis.
Cellular Photo-Defense Capsules
Systemic antioxidant matrix of Polypodium Leucotomos, astaxanthin, and liposomal glutathione reducing photo-aging cascade.
12-Week Multi-Center Clinical Evaluation
High-frequency dermal ultrasound measurements across 140 patients demonstrated marked increase in dermis echogenicity and sub-epidermal low echogenic band (SLEB) reduction:
